An interventional study of ERAS and DEEPSEN in Digestive Emergency, New Pathway and Connected Health, sponsored by Centre Hospitalier Universitaire, Amiens. Recruiting at 6 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-02.
Sponsored by Centre Hospitalier Universitaire, Amiens · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
The number of emergencies's visits (22 million visits in 2019 in France), the organization of emergencies and the sustainability of the current health system are threatened. In the CHUAP adult emergency department, 60,000 visits were recorded in 2022.
Unlike medical emergencies which have structured their care and research activities (heart, brain), and whose organization has demonstrated its general interest for society, digestive surgical emergencies, which involve complex patients (elderly people, comorbidities) , emergency situations and surgical procedures, have never been thought of globally in terms of personalized care and research pathways. Currently, patients treated in emergency are managed without a pre-established optimization program and without a dedicated pathway, where emergency constitutes a major risk factor for postoperative complications.
RAUCAMIENS evaluates a new care pathway implemented within the framework of the RHU RAUC : the implementation of the Enhanced rehabilitation after surgery (ERAS) and e-health devices for home monitoring, for patients treated in the emergency room for a digestive pathology. The purpose is to evaluate the effectiveness of the RAUC pathway in reducing the rate of unplanned hospitalization readmission after emergency digestive surgery 30 days postoperative.
Centre Hospitalier Universitaire, Amiens is the lead sponsor of 586 studies on the registry; 185 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Criterion linked to the protocol :
-- Patient consulted in emergency for a digestive pathology requiring surgery
Search criteria:
Exclusion Criteria:
Criterion linked to the protocol:
Search criteria:
patients included in the CHUAP RAUC + course
Other: ERAS · Other: DEEPSEN · Other: RDS · Other: Get ready · Other: Lumiradx · Other: Digital Surgery
patients from other hospital included over the same period as patients from CHUAP benefiting from standard care (RAUC -)
Other: ERAS
patients verifying the inclusion/non-inclusion criteria and from the SNDS over the period from January 1, 2022 to December 31, 2025
Other: ERAS
ERAS
virtual reality headset to reduce anxiety
patch to continuously monitor patients' physiological parameters at home
digital solution for managing patients at home
taking CRP at home
recording of the different operating times
Occurrence of an unscheduled hospitalization readmission
Occurrence of an unscheduled hospitalization readmission following digestive surgery performed urgently within 30 days
Time frame: 30 days
assess morbidity and mortality
Clavien-Dindo score
Time frame: 30 days
evaluaate the effectiveness of the RAUC pathway on the lenght of hospital stay on first admission for emergency digestive surgery
lenght of hospital stay for first admission for emergency digestive surgery
Time frame: 30 days
evaluate the quality of life of patients with or without a RAUC pathway
Quality of life assessed by the scores of the different dimensions of the EQ-5D-5L which is a PROMS, at admission and the postoperative visit
Time frame: 0 day
Assessing patient anxietys
Anxiety assessed by a VAS
Time frame: 30 days
assess wether the patient has returned to the emergency department without being hospitalized
non-hospitalized emergency room visits
Time frame: 0 day
medico economic evaluation of the RAUC pathway
incremental cost-utility ratio (cost/QALY) and ncremental cost-effectiveness ratio (cost per readmission avoided)
Time frame: 30 days
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Jul 2027, 25 months after the start.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 2, 2026: primary completion Nov 2026 → Jul 2027 and completion Aug 2027 → Feb 2028.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre Hospitalier Universitaire, Amiens →